X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (65733) 65733
Newsletter (1629) 1629
Magazine Article (596) 596
Newspaper Article (466) 466
Book Chapter (107) 107
Book / eBook (54) 54
Conference Proceeding (40) 40
Dissertation (39) 39
Web Resource (31) 31
Transcript (26) 26
Publication (10) 10
Streaming Video (10) 10
Reference (9) 9
Journal / eJournal (8) 8
Government Document (5) 5
Paper (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51354) 51354
male (23480) 23480
female (23448) 23448
staphylococcal infections - microbiology (18779) 18779
staphylococcus aureus (15792) 15792
staphylococcal infections - drug therapy (14786) 14786
animals (14285) 14285
adult (13549) 13549
staphylococcal infections (13100) 13100
middle aged (12700) 12700
microbiology (10601) 10601
infectious diseases (10205) 10205
aged (9772) 9772
anti-bacterial agents - therapeutic use (9161) 9161
staphylococcal infections - epidemiology (9010) 9010
staphylococcus aureus - drug effects (8321) 8321
staphylococcus aureus - isolation & purification (7683) 7683
staphylococcal infections - diagnosis (7208) 7208
child (6835) 6835
adolescent (6730) 6730
methicillin resistance (6589) 6589
microbial sensitivity tests (6488) 6488
anti-bacterial agents - pharmacology (6441) 6441
infections (6413) 6413
health aspects (5731) 5731
infection (5728) 5728
staphylococcal infections - complications (5696) 5696
staphylococcal infections - prevention & control (5520) 5520
staphylococcal infections - etiology (5168) 5168
infant (5096) 5096
mice (4764) 4764
methicillin-resistant staphylococcus aureus - isolation & purification (4639) 4639
child, preschool (4534) 4534
risk factors (4521) 4521
immunology (4421) 4421
staphylococcus aureus infections (4082) 4082
antibiotics (4045) 4045
research (3948) 3948
retrospective studies (3938) 3938
infant, newborn (3929) 3929
staphylococcus aureus - genetics (3926) 3926
surgery (3900) 3900
staphylococcus (3852) 3852
methicillin-resistant staphylococcus aureus (3806) 3806
mrsa (3742) 3742
prevalence (3647) 3647
epidemiology (3569) 3569
pharmacology & pharmacy (3537) 3537
aged, 80 and over (3499) 3499
drug resistance in microorganisms (3431) 3431
treatment outcome (3399) 3399
bacteria (3299) 3299
staphylococcal infections - veterinary (3258) 3258
cross infection - microbiology (3253) 3253
staphylococcal infections - immunology (3216) 3216
methicillin-resistant staphylococcus aureus - drug effects (3037) 3037
staphylococcus infections (2933) 2933
analysis (2921) 2921
bacteremia (2911) 2911
staphylococcal infections - therapy (2847) 2847
cross infection - epidemiology (2795) 2795
medicine, general & internal (2689) 2689
research article (2685) 2685
anti-bacterial agents - administration & dosage (2664) 2664
hospitals (2663) 2663
time factors (2660) 2660
vancomycin (2550) 2550
staphylococcus - isolation & purification (2470) 2470
staphylococcal infections - pathology (2414) 2414
strains (2414) 2414
staphylococcus aureus - pathogenicity (2408) 2408
virulence (2400) 2400
drug resistance (2397) 2397
nosocomial infections (2375) 2375
cross infection (2348) 2348
pediatrics (2308) 2308
methicillin-resistant staphylococcus aureus - genetics (2286) 2286
prospective studies (2231) 2231
cross infection - prevention & control (2220) 2220
disease models, animal (2211) 2211
drug resistance, microbial (2178) 2178
cattle (2156) 2156
staphylococcal infections - surgery (2108) 2108
methicillin-resistant (2074) 2074
young adult (2071) 2071
care and treatment (2065) 2065
rabbits (2046) 2046
bacterial proteins - genetics (2042) 2042
diagnosis (2039) 2039
biochemical phenomena, metabolism, and nutrition (2036) 2036
medical research (2028) 2028
bacteremia - microbiology (2021) 2021
colonization (2020) 2020
mortality (1984) 1984
staphylococcus - drug effects (1924) 1924
skin (1891) 1891
staphylococcal infections - transmission (1889) 1889
methicillin (1884) 1884
staphylococcus aureus - classification (1849) 1849
vancomycin - therapeutic use (1845) 1845
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (32) 32
Online Resources - Online (31) 31
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Gerstein Science - Periodical Stacks (4) 4
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Circulation Desk (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (58201) 58201
Russian (2850) 2850
French (2047) 2047
German (1872) 1872
Japanese (1403) 1403
Spanish (1313) 1313
Polish (613) 613
Italian (605) 605
Portuguese (318) 318
Chinese (251) 251
Czech (208) 208
Dutch (204) 204
Danish (158) 158
Romanian (140) 140
Ukrainian (122) 122
Hungarian (111) 111
Turkish (106) 106
Swedish (100) 100
Norwegian (85) 85
Finnish (45) 45
Bulgarian (44) 44
Serbian (43) 43
Hebrew (40) 40
Korean (35) 35
Croatian (28) 28
Slovak (19) 19
Lithuanian (5) 5
Greek (4) 4
Icelandic (3) 3
Afrikaans (2) 2
Arabic (2) 2
Armenian (2) 2
Persian (2) 2
Albanian (1) 1
Catalan (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of hospital infection, ISSN 0195-6701
Journal
Journal
Clinical orthopaedics and related research, ISSN 1528-1132, 2013, Volume 471, Issue 7, pp. 2383 - 2399
Staphylococcus aureus is the most common organism responsible for orthopaedic surgical site infections (SSIs... 
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | SURGERY | COST-EFFECTIVENESS | HOSPITAL STAFF | ACTIVE SURVEILLANCE | MRSA | ERADICATION | OF-THE-LITERATURE | ORTHOPEDICS | NASAL CARRIAGE | INTRANASAL MUPIROCIN | WOUND INFECTIONS | NOSOCOMIAL INFECTIONS | Community-Acquired Infections - diagnosis | Community-Acquired Infections - therapy | Community-Acquired Infections - transmission | Hospital Costs | Cross Infection - economics | Humans | Orthopedic Procedures - adverse effects | Infection Control - methods | Cost Savings | Cross Infection - transmission | Staphylococcal Infections - microbiology | Surgical Wound Infection - transmission | Cross Infection - prevention & control | Mass Screening - economics | Community-Acquired Infections - economics | Surgical Wound Infection - economics | Anti-Infective Agents - therapeutic use | Treatment Outcome | Staphylococcal Infections - therapy | Staphylococcal Infections - transmission | Surgical Wound Infection - prevention & control | Staphylococcal Infections - diagnosis | Staphylococcal Infections - economics | Cost-Benefit Analysis | Cross Infection - microbiology | Surgical Wound Infection - diagnosis | Cross Infection - diagnosis | Orthopedic Procedures - economics | Staphylococcal Infections - prevention & control | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Program Evaluation | Surgical Wound Infection - microbiology | Community-Acquired Infections - microbiology | Infection Control - economics | Online health care information services | Orthopedic surgery | Health aspects | Analysis | Staphylococcal infections | Staphylococcus aureus | Survey
Journal Article
Burns, ISSN 0305-4179, 2017, Volume 43, Issue 3, pp. 642 - 653
Highlights • Burn depth/agent increases risk of developing an infection. • Infections found folliculitis, burn wound, urinary tract, pneumonia, CVC and bloodstream... 
Critical Care | Nosocomial infection | Burn wound infection | Pneumonia | Urinary tract infection | Health care related infection | Burns | URINARY-TRACT-INFECTION | MORTALITY | SURGERY | RISK-FACTORS | DERMATOLOGY | REPLACEMENT | BACTERIOLOGY | CATHETERS | INTENSIVE-CARE-UNIT | SURVEILLANCE | ASSOCIATION | BLOOD-STREAM INFECTIONS | CRITICAL CARE MEDICINE | Escherichia coli | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Folliculitis - epidemiology | Aged, 80 and over | Urinary Tract Infections - microbiology | Catheter-Related Infections - epidemiology | Child | Infant, Newborn | Staphylococcus aureus | Escherichia coli Infections - drug therapy | Bacteremia - drug therapy | Pseudomonas Infections - microbiology | Wound Infection - epidemiology | Catheter-Related Infections - drug therapy | Drug Resistance, Microbial | Escherichia coli Infections - epidemiology | Acinetobacter baumannii | Catheter-Related Infections - microbiology | Adolescent | Bacteremia - epidemiology | Infant | Bacteremia - microbiology | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Adult | Female | Pseudomonas aeruginosa | Staphylococcal Infections - microbiology | Wound Infection - drug therapy | Acinetobacter Infections - microbiology | Staphylococcal Infections - drug therapy | Colombia - epidemiology | Klebsiella Infections - drug therapy | Central Venous Catheters | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Folliculitis - microbiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Oxacillin - therapeutic use | Burns - epidemiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Wound Infection - microbiology | Aged | Folliculitis - drug therapy | Klebsiella pneumoniae | Development and progression | Burns and scalds | Surgery, Plastic | Health aspects | Staphylococcus aureus infections | Analysis | Bacterial pneumonia | Mortality | Urinary tract infections | Bacteria | Disease susceptibility | Antibacterial agents
Journal Article
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2008, Volume 321, Issue 5889, pp. 691 - 696
...). MyD88 deficiency in mice leads to susceptibility to a broad range of pathogens in experimental settings of infection... 
Receptors | Phenotypes | Transfection | Cytokines | HEK293 cells | Genes | Cell lines | Fibroblasts | Agonists | Reports | Children | MYD88-DEFICIENT MICE | HERPES-SIMPLEX-VIRUS | PROTECTIVE IMMUNITY | MYELOID DIFFERENTIATION FACTOR-88 | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | HUMORAL IMMUNITY | STAPHYLOCOCCUS-AUREUS | AERUGINOSA LUNG INFECTION | HOST RESPONSE | CUTTING EDGE | Humans | Child, Preschool | Male | Mutation, Missense | Bacterial Infections - genetics | Pneumococcal Infections - immunology | Bacterial Infections - immunology | Gene Deletion | Pneumococcal Infections - genetics | Female | Toll-Like Receptors - metabolism | Child | Staphylococcal Infections - genetics | Disease Susceptibility | Cytokines - metabolism | Signal Transduction | Staphylococcal Infections - immunology | Receptors, Interleukin-1 - immunology | Toll-Like Receptors - immunology | Myeloid Differentiation Factor 88 - genetics | Immunity, Innate | Pseudomonas Infections - genetics | Pseudomonas Infections - immunology | Receptors, Interleukin-1 - metabolism | Animals | Myeloid Differentiation Factor 88 - deficiency | Adolescent | Mice | Myeloid Differentiation Factor 88 - metabolism | Cell Line, Transformed | Genetic aspects | Bacterial infections | Pediatrics | Bacteria | Biomedical research | Genetic disorders | Immunology | Pneumococcal Infections | Life Sciences | Toll-Like Receptors | Bacterial Infections | Myeloid Differentiation Factor 88 | Bacteriology | Staphylococcal Infections | Microbiology and Parasitology | Pseudomonas Infections | Receptors, Interleukin-1
Journal Article
PloS one, ISSN 1932-6203, 05/2012, Volume 7, Issue 5, p. e37281
Formation of resilient biofilms on medical devices colonized by pathogenic microorganisms is a major cause of health-care associated infection... 
ANTIBIOTIC-LOCK TECHNIQUE | CONTROLLED-TRIAL | DIAGNOSIS | THERAPY | BACTEREMIA | IN-VIVO | BIOLOGY | ACCESS SYSTEM | MICE | CANCER | BLOOD-STREAM INFECTIONS | Staphylococcal Infections - drug therapy | Cefazolin - therapeutic use | Gentamicins - therapeutic use | Biofilms - growth & development | Pseudomonas Infections - complications | Rats | Male | Equipment Contamination | Staphylococcal Infections - complications | Anti-Bacterial Agents - therapeutic use | Animals | Staphylococcus epidermidis | Immunosuppression - adverse effects | Catheters, Indwelling - adverse effects | Models, Animal | Pseudomonas aeruginosa | Catheterization, Central Venous - adverse effects | Escherichia coli Infections - complications | Medical research | Medical equipment | Bacterial infections | Escherichia coli | Staphylococcus aureus infections | Medicine, Experimental | Cross infection | Nosocomial infections | Health aspects | Physiological apparatus | Staphylococcus aureus | Pediatrics | Surgical implants | Bioluminescence | Medical innovations | Disseminated infection | Clinical trials | Infections | Microorganisms | E coli | Bacteria | Pathogens | Medical devices | Stability | Complications | Medical instruments | Staphylococcus infections | Disease control | Contamination | Catheters | Biofilms | Antibiotics | Colonization | Cefazolin/therapeutic use | Escherichia coli infections | Biofilms/growth & development | Central Venous/adverse effects | Life Sciences | Staphylococcal Infections/complications/drug therapy | Pseudomonas Infections/complications | Bloodstream infections | Immunosuppression/adverse effects | Bacterial biofilms | Gentamicins/therapeutic use | Catheterization | Indwelling/adverse effects | Escherichia coli Infections/complications | bacterial pathogens | Bacteriology | Microbiology and Parasitology | Animal | Models | Anti-Bacterial Agents/therapeutic use
Journal Article
The American journal of emergency medicine, ISSN 0735-6757, 2017, Volume 35, Issue 4, pp. 579 - 583
...) from gram-positive (GP) bloodstream infections and determining the relationship between PCT levels, infection sites, and pathogen types... 
Emergency | Positive blood culture | Procalcitonin | Bacterial species | Gram-positive bacteria | Sepsis | Gram-negative bacteria | Infection sites | DIAGNOSIS | MANAGEMENT | ANTIBIOTIC USE | GUIDELINES | MARKERS | CALCITONIN | EMERGENCY MEDICINE | SEPTIC SHOCK | SERUM PROCALCITONIN | RESPIRATORY-TRACT INFECTIONS | Enterococcus faecalis | Escherichia coli | Humans | Middle Aged | Escherichia coli Infections - blood | Male | Acinetobacter Infections - blood | Bacteremia - microbiology | Gram-Negative Bacterial Infections - microbiology | Endocarditis, Bacterial - blood | Staphylococcus haemolyticus | Burkholderia cepacia | Gram-Positive Bacterial Infections - microbiology | Aged, 80 and over | Bacteremia - blood | Endocarditis, Bacterial - microbiology | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Staphylococcal Infections - microbiology | Klebsiella Infections - blood | Burkholderia Infections - microbiology | Staphylococcal Infections - blood | Staphylococcus aureus | Acinetobacter Infections - microbiology | Pneumonia, Bacterial - blood | Calcitonin - blood | Emergency Service, Hospital | Intensive Care Units | Pneumonia, Bacterial - microbiology | Escherichia coli Infections - microbiology | Biomarkers - blood | Klebsiella Infections - microbiology | Gram-Positive Bacterial Infections - blood | Enterococcus faecium | Staphylococcus hominis | Acinetobacter baumannii | Urinary Tract Infections - blood | Staphylococcus epidermidis | Catheter-Related Infections - blood | Catheter-Related Infections - microbiology | Gram-Negative Bacterial Infections - blood | Aged | Burkholderia Infections - blood | Klebsiella pneumoniae | Bacteria | Health aspects | Medical research | Medical examination | Microbiology | Emergency medicine | Analysis | Endocarditis | Medicine, Experimental | Urinary tract infections | Blood | Lupus | Klebsiella | Pathogens | Multiple sclerosis | Intensive care | Pneumonia | Bacterial infections | Disease | Laboratories | Lung cancer | Medical instruments | Infections | Arthritis | Family medical history | Urinary tract | Patients | Microorganisms | Thyroid cancer | Biomarkers | Cutoffs | Diagnostic systems
Journal Article
American journal of respiratory and critical care medicine, ISSN 1535-4970, 2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy
Journal Article
Hospital infection control, ISSN 0098-180X
Journal
Journal of preventive medicine and hygiene, ISSN 1121-2233, 2017, Volume 58, Issue 4, pp. E294 - E301
National efforts to curtail healthcare-associated infections (HAI) proliferated recently, though data detailing progress over time are limited... 
Bloodstream infections | Urinary tract infections | Antimicrobial resistance | Multidrug-resistant organisms | Surgical site infections | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Incidence | Gram-Negative Bacterial Infections - microbiology | Young Adult | Gram-Positive Bacterial Infections - microbiology | Urinary Tract Infections - microbiology | Odds Ratio | Staphylococcus aureus | Enterococcus | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Logistic Models | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Streptococcus pneumoniae | Acinetobacter baumannii | Cross Infection - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | New York City - epidemiology | Surgical Wound Infection - microbiology | Gram-Positive Bacterial Infections - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Surgical Wound Infection - drug therapy | Adult | Female | Pseudomonas aeruginosa | Retrospective Studies | Staphylococcal Infections - microbiology | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Streptococcal Infections - microbiology | Staphylococcal Infections - drug therapy | Surgical Wound Infection - epidemiology | Klebsiella Infections - drug therapy | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Streptococcal Infections - epidemiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Streptococcal Infections - drug therapy | Aged | Klebsiella pneumoniae
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2015, Volume 61, Issue suppl 2, pp. S69 - S78
Skin and soft-tissue infections (SSTIs) are an important cause of morbidity and mortality among hospitalized patients and a major therapeutic challenge for clinicians... 
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | UNITED-STATES | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | NECROTIZING FASCIITIS | CARE-ASSOCIATED INFECTIONS | MICROBIOLOGY | IMMUNOLOGY | COMPLICATED SKIN | STREPTOCOCCAL INFECTIONS | STAPHYLOCOCCUS-AUREUS INFECTIONS | SURGICAL SITE INFECTION | EPIDEMIOLOGY | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 2009, Volume 34, Issue 1, pp. S2 - S7
Abstract Skin and soft tissue infections (SSTIs) are common and range in severity from minor, self-limiting, superficial infections to life-threatening diseases requiring all the resources of modern medicine... 
Infectious Disease | Community-acquired infections | Hospital infections | Staphylococci | Skin and soft tissue infections | Meticillin-resistant Staphylococcus aureus | Risk factors | Aetiology | INFECTIOUS DISEASES | ANTIBIOTICS | MANAGEMENT | PASTEURELLA-MULTOCIDA | GUIDELINES | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | WOUND INFECTIONS | COMMUNITY | PANTON-VALENTINE LEUKOCIDIN | SURVEILLANCE | PHARMACOLOGY & PHARMACY | TOXIC-SHOCK-SYNDROME | Streptococcal Infections - microbiology | Skin Diseases, Bacterial - microbiology | Community-Acquired Infections - epidemiology | Staphylococcal Skin Infections - epidemiology | Bacterial Infections - drug therapy | Humans | Streptococcal Infections - epidemiology | Soft Tissue Infections - epidemiology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Skin Diseases, Bacterial - epidemiology | Streptococcus - isolation & purification | Cross Infection - microbiology | Bacterial Infections - epidemiology | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Staphylococcal Skin Infections - microbiology | Bacterial Infections - microbiology | Cross Infection - epidemiology | Cross infection | Nosocomial infections | Microbiology | Health aspects | Epidemiology | Staphylococcus aureus infections
Journal Article